Partners in Biomaterials

Partners in Biomaterials was a California-based biotechnology and medical device company specializing in the development of advanced hydrogel technologies for therapeutic and surgical applications. The company's proprietary platform utilized cross-linked hyaluronic acid and poly-N-vinylpyrrolidone (PVP) to create biocompatible bulking agents and drug delivery systems. Its primary commercial success was the Oasis Form Fit Canalicular Plug, an FDA-cleared device for treating dry eye syndrome by occluding the lacrimal drainage system. Partners in Biomaterials also established strategic licensing agreements with companies like Aquamer Medical Corp to apply its hydrogel technology in the fields of dermatology, urology, and gastroenterology, notably for the treatment of gastroesophageal reflux disease (GERD).